Less than five months ago, the FDA approved the first completely drug-free, device-based treatment option to help asthmatic adults gain control over the condition. Now, Boston Scientific (Natick, Massachusetts) says it plans to buy Asthmatx (Sunnyvale, California), the company that makes the Alair bronchial thermoplasty system, for an upfront payment of $193.5 million and additional payments of up to $250 million. (Medical Device Daily) Read More
